FDA Approves METHADONE HYDROCHLORIDE — Ascend Laboratories, LLC
Ascend Laboratories, LLC secured FDA approval for its generic Methadone Hydrochloride product, a move expected to bolster the company's footprint in the opioid dependence treatment market. By establishing a low-cost alternative to existing branded products, Ascend is poised to gain market share and drive revenue growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day